[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335045-105":59,"doc-detail-335045-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","comparison-of-multiplex-pcr-capillary-electrophoresis-assay-and-pcr-reverse-dot-blot-assay-for-human-papillomavirus-dna-genotyping-detection-in-cervical-cancer-tissue-specimens","Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens","","A comparative study evaluates positivity rates and genotype distributions of multiplex PCR capillary electrophoresis (MPCE) and PCR-reverse dot blot (PCR-RDB) assays for detecting human papillomavirus (HPV) DNA in cervical cancer tissue specimens. The assays were applied separately to 425 confirmed specimens, and outcomes were compared using HPV infection positivity and genotype distribution metrics. MPCE showed higher overall positivity (97.9% vs 92.9%), with statistical significance in consistency (p\u003C0.001) and a fair agreement (kappa=0.390). The study concludes MPCE can reduce false negatives and support efficient population screening.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparison-of-multiplex-pcr-capillary-electrophoresis-assay-and-pcr-reverse-dot-blot-assay-for-human-papillomavirus-dna-genotyping-detection-in-cervical-cancer-tissue-specimens/335045/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparison-of-multiplex-pcr-capillary-electrophoresis-assay-and-pcr-reverse-dot-blot-assay-for-human-papillomavirus-dna-genotyping-detection-in-cervical-cancer-tissue-specimens/335045.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the primary goal of comparing MPCE and PCR-RDB assays?","Question",{"text":112,"@type":113},"To evaluate positivity rates and genotype distribution for HPV detection in cervical cancer tissue specimens and to clarify detection principles and large-scale screening applications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the MPCE and PCR-RDB assays implemented in the study?",{"text":117,"@type":113},"Both assays were performed separately on 425 diagnosed cervical cancer tissue specimens, and results were compared based on HPV positivity rates and genotype distribution.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about overall HPV positivity and agreement between assays?",{"text":121,"@type":113},"Overall positive rates were 97.9% for MPCE and 92.9% for PCR-RDB. Consistency differed significantly (p\u003C0.001) with a fair agreement (kappa=0.390).",{"name":123,"@type":110,"acceptedAnswer":124},"Why does the study recommend extending the MPCE assay?",{"text":125,"@type":113},"MPCE targets oncogenic E6/E7 segments and is proposed to reduce false-negative rates and improve screening efficiency for early detection, diagnosis, and treatment of cervical cancer.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335045,1790727461,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 19 July 2024  \nDOI 10.3389/fpubh.2024.1421774  \nOPEN ACCESS  \nEDITED BY  \nMarina Pekmezovic,  \nIndependent Researcher, Berlin, Germany  \nREVIEWED BY  \nAbdou Kamal Allayeh,  \nNational Research Centre, Egypt Leabaneng Tawe,  \nBotswana-UPenn Partnership (BUP), Botswana  \nMarcus Batista,  \nFederal University of Sergipe, Brazil  \n*CORRESPONDENCE  \nJianxiang Geng  \n [njgjx2022@163.com](njgjx2022@163.com)  \nRECEIVED 23 April 2024  \nACCEPTED 09 July 2024  \nPUBLISHED 19 July 2024  \nCITATION  \nQin L, Li D, Wang Z, Lan J, Han C, Mei J and Geng J (2024) Comparison of multiplex PCR capillary electrophoresis assay and  \nPCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens.  \nFront. Public Health 12:1421774 .  \ndoi: 10.3389/fpubh.2024.1421774  \nCOPYRIGHT  \n© 2024 Qin, Li, Wang, Lan, Han, Mei and Geng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens  \nLei Qin 1, Dan Li 1, Zhihui Wang 2, Jianyun Lan3, Chunrong Han4, Jing Mei 5 and Jianxiang Geng 1, 6*  \n1 Nanjing Leiyue Clinical Laboratory, Nanjing, Jiangsu, China, 2 Department of Pathology, Linyi Cancer Hospital, Linyi, Shangdong, China, 3 Department of Pathology, Yancheng First People’s Hospital, Yancheng, Jiangsu, China, 4 Department of Pathology, Nanjing Lishui District People’s Hospital, Nanjing, Jiangsu, China, 5 Department of Pathology, People’s Hospital of Dangtu, Ma'anshan, Anhui, China, 6The Cross-Strait Precision Medicine Association HPV Infection Disease Professional Committee, Nanjing, China  \nBackground: The study aimed to evaluate the positivity rates and genotype distribution of the multiplex PCR capillary electrophoresis (MPCE) and PCRReverse Dot Blot (PCR-RDB) assays for human papillomavirus (HPV) detection in cervical cancer tissue specimens, and to explore their detection principles and applications in large-scale population screening.  \nMethods: The MPCE and PCR-RDB assays were performed separately on 425 diagnosed cervical cancer tissue specimens. Subsequently, the results of both assays were compared based on the HPV infection positivity rates and genotype distribution.  \nResults: The overall positive rates of HPV genotypes for the MPCE and PCRRDB assays were 97.9% and 92.9%, respectively. A p-value \u003C 0.001 indicated a statistically significance difference in consistency between the two assays. The kappa value was 0.390, indicating that the consistency between both assays was fair. HPV16 was the most common single-genotype infection type, with infection rates detected via MPCE and PCR-RDB assays being 75.7% and 68.3%, respectively. In the age group >50 years, the HPV multiple-type infection rate detected via MPCE assay was significantly higher than that detected by the PCRRDB assay, with a statistically significant difference (p = 0.002) .  \nConclusion: To reduce the false-negative rate and improve screening efficiency, the MPCE assay, which targets the oncogenic gene E6/E7 segments, can be extended to the general female population for the early detection, diagnosis, and treatment of cervical cancer.  \nKEYWORDS  \nHPV DNA detection, polymerase chain reaction, cervical cancer tissue specimen, multiplex PCR capillary electrophoresis assay, PCR-reverse dot blot assay  \nFrontiers in Public Health 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nCervical cancer ranks as the fourth most common malignant tumor","cbCaihlKP2t9Du0i","https://ap.wps.com/l/cbCaihlKP2t9Du0i","pdf",649639,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the primary goal of comparing MPCE and PCR-RDB assays?\",\"answer\":\"To evaluate positivity rates and genotype distribution for HPV detection in cervical cancer tissue specimens and to clarify detection principles and large-scale screening applications.\"},{\"question\":\"How were the MPCE and PCR-RDB assays implemented in the study?\",\"answer\":\"Both assays were performed separately on 425 diagnosed cervical cancer tissue specimens, and results were compared based on HPV positivity rates and genotype distribution.\"},{\"question\":\"What did the results show about overall HPV positivity and agreement between assays?\",\"answer\":\"Overall positive rates were 97.9% for MPCE and 92.9% for PCR-RDB. Consistency differed significantly (p\\u003c0.001) with a fair agreement (kappa=0.390).\"},{\"question\":\"Why does the study recommend extending the MPCE assay?\",\"answer\":\"MPCE targets oncogenic E6/E7 segments and is proposed to reduce false-negative rates and improve screening efficiency for early detection, diagnosis, and treatment of cervical cancer.\"}]","Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens | PDF",1790009446,23]